New treatment possibility for some cancer patients
Intended for healthcare professionals

Cancer Nursing Practice

Clinical update Previous     Next

New treatment possibility for some cancer patients

Lynne Pearce Health writer
Share to Facebook Share to X Share to Whatsapp Share to Email More...

Essential information

Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use.

Cancer Nursing Practice. 19, 4, 12-12. doi: 10.7748/cnp.19.4.12.s9

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now

Are you a student? Our student subscription has content especially for you.
Find out more

Organisational access
Read this article via your institutional log in or pair token
Don’t have access via your organisation? Recommend to your librarian

09 July 2020 / Vol 19 issue 4

TABLE OF CONTENTS

DIGITAL EDITION

SUBSCRIBE

Journals